StockWatch
·
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Management ChangeMay 15, 2026, 04:52 PM

VolitionRx Director Henshall Not to Seek Re-election; Board Shrinks to 7

AI Summary

VolitionRx Limited announced that Mickie Henshall will not seek re-election to its Board of Directors at the 2026 Annual Meeting. Ms. Henshall has been a board member since August 2022, and her decision was not due to any disagreements with the company's operations or policies. As a result, the Board will reduce its size from eight to seven directors, effective immediately prior to the 2026 Annual Meeting.

Key Highlights

  • Director Mickie Henshall will not stand for re-election at the 2026 Annual Meeting.
  • Ms. Henshall has served on the Board since August 2022.
  • The Board will reduce its size from eight to seven directors.
  • The change is effective immediately prior to the 2026 Annual Meeting.
  • Her decision did not involve any disagreement with the company.